+4.4%
PLTR vs GSK
+24.6%
-20.2%
-48.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | +0.2% | -0.6% | -0.4% |
| 7D | 0.0% | -3.6% | +3.6% | -0.5% |
| 30D | -3.3% | -5.9% | +2.7% | -4.2% |
| 3M | +28.4% | -4.3% | +32.6% | +27.7% |
| 6M | +8.4% | -10.8% | +19.2% | +6.6% |
| YTD | -4.6% | +1.8% | -6.4% | -7.2% |
| 1Y | +4.4% | +23.5% | -19.1% | -1.0% |
| All | +4.4% | +24.6% | -20.2% | -1.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling